These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 37286948

  • 1. Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression.
    Elíasdóttir S, Khramova A, Saeed A, Guron G, Boi R, Mölne J, Ebefors K, Nyström J.
    BMC Nephrol; 2023 Jun 07; 24(1):160. PubMed ID: 37286948
    [Abstract] [Full Text] [Related]

  • 2. Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
    Bagchi S, Lingaiah R, Mani K, Barwad A, Singh G, Balooni V, Bhowmik D, Agarwal SK.
    PLoS One; 2019 Jun 07; 14(3):e0214256. PubMed ID: 30917188
    [Abstract] [Full Text] [Related]

  • 3. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
    Suzuki H, Allegri L, Suzuki Y, Hall S, Moldoveanu Z, Wyatt RJ, Novak J, Julian BA.
    Dis Markers; 2016 Jun 07; 2016():7806438. PubMed ID: 27647947
    [Abstract] [Full Text] [Related]

  • 4. A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.
    Yanagawa H, Suzuki H, Suzuki Y, Kiryluk K, Gharavi AG, Matsuoka K, Makita Y, Julian BA, Novak J, Tomino Y.
    PLoS One; 2014 Jun 07; 9(5):e98081. PubMed ID: 24858067
    [Abstract] [Full Text] [Related]

  • 5. Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy.
    Irabu H, Shimizu M, Kaneko S, Inoue N, Mizuta M, Ohta K, Yachie A.
    J Immunol Res; 2020 Jun 07; 2020():4284379. PubMed ID: 32537466
    [Abstract] [Full Text] [Related]

  • 6. Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis.
    Zhang X, Xie X, Shi S, Liu L, Lv J, Zhang H.
    Nephrol Dial Transplant; 2020 Dec 04; 35(12):2117-2123. PubMed ID: 31377786
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    Wada Y, Matsumoto K, Suzuki T, Saito T, Kanazawa N, Tachibana S, Iseri K, Sugiyama M, Iyoda M, Shibata T.
    PLoS One; 2018 Dec 04; 13(11):e0206865. PubMed ID: 30388165
    [Abstract] [Full Text] [Related]

  • 8. Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability.
    Hastings MC, Moldoveanu Z, Julian BA, Novak J, Sanders JT, McGlothan KR, Gharavi AG, Wyatt RJ.
    Clin J Am Soc Nephrol; 2010 Nov 04; 5(11):2069-74. PubMed ID: 20634323
    [Abstract] [Full Text] [Related]

  • 9. Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy.
    Kim JS, Hwang HS, Lee SH, Kim YG, Moon JY, Kong JY, Jeong KH.
    J Clin Med; 2020 Nov 04; 9(11):. PubMed ID: 33158064
    [Abstract] [Full Text] [Related]

  • 10. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
    Martín-Penagos L, Fernández-Fresnedo G, Benito-Hernández A, Mazón J, de Cos M, Oviedo MV, San Segundo D, López-Hoyos M, Gómez-Román J, Ruiz JC, Rodrigo E.
    Nefrologia (Engl Ed); 2021 Nov 04; 41(3):311-320. PubMed ID: 36166247
    [Abstract] [Full Text] [Related]

  • 11. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
    Sugiyama M, Wada Y, Kanazawa N, Tachibana S, Suzuki T, Matsumoto K, Iyoda M, Honda H, Shibata T.
    PLoS One; 2020 Nov 04; 15(4):e0232194. PubMed ID: 32324811
    [Abstract] [Full Text] [Related]

  • 12. Porphyromonas gingivalis infection in the oral cavity is associated with elevated galactose-deficient IgA1 and increased nephritis severity in IgA nephropathy.
    Ito S, Misaki T, Nagasawa Y, Nomura R, Naka S, Fukunaga A, Matsuoka D, Matayoshi S, Matsumoto-Nakano M, Nakano K.
    Clin Exp Nephrol; 2024 Mar 04; 28(3):192-200. PubMed ID: 37806974
    [Abstract] [Full Text] [Related]

  • 13. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L, Peng L, Yang D, Chen S, Lan Z, Zhu X, Yuan S, Chen G, Liu Y, Liu H.
    Clin Immunol; 2020 Aug 04; 217():108483. PubMed ID: 32479989
    [Abstract] [Full Text] [Related]

  • 14. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
    Zhang K, Li Q, Zhang Y, Shang W, Wei L, Li H, Gao S, Yan T, Jia J, Liu Y, Lin S.
    Kidney Blood Press Res; 2019 Aug 04; 44(5):1196-1206. PubMed ID: 31574506
    [Abstract] [Full Text] [Related]

  • 15. Serum and urine galactose deficient-IgA1 as alternative biomarkers in the management of IgA nephropathy.
    Suleman AA, Abd Ghani F, Fadhlina NZ, Rafidah H.
    Med J Malaysia; 2024 Jan 04; 79(1):95-101. PubMed ID: 38287764
    [Abstract] [Full Text] [Related]

  • 16. TLR7 in B cells promotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy.
    Zheng N, Xie K, Ye H, Dong Y, Wang B, Luo N, Fan J, Tan J, Chen W, Yu X.
    JCI Insight; 2020 Jul 23; 5(14):. PubMed ID: 32699192
    [Abstract] [Full Text] [Related]

  • 17. A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy.
    Temurhan S, Akgul SU, Caliskan Y, Artan AS, Kekik C, Yazici H, Demir E, Caliskan B, Turkmen A, Oguz FS, Sever MS.
    Transplant Proc; 2017 Apr 23; 49(3):541-545. PubMed ID: 28340830
    [Abstract] [Full Text] [Related]

  • 18. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
    Martín-Penagos L, Fernández-Fresnedo G, Benito-Hernández A, Mazón J, de Cos M, Oviedo MV, San Segundo D, López-Hoyos M, Gómez-Román J, Ruiz JC, Rodrigo E.
    Nefrologia (Engl Ed); 2021 Apr 23; 41(3):311-320. PubMed ID: 33741175
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of galactose-deficient IgA1 in Chinese children with IgA nephropathy, IgA vasculitis with nephritis, and IgA vasculitis.
    Tang M, Zhang X, Li X, Lei L, Zhang H, Ling C, Ni J, Lv J, Liu X, Chen X.
    Clin Exp Nephrol; 2021 Jan 23; 25(1):37-43. PubMed ID: 32935202
    [Abstract] [Full Text] [Related]

  • 20. Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA1 Antibody in IgA Nephropathy Patients.
    Chiu YL, Lin WC, Shu KH, Fang YW, Chang FC, Chou YH, Wu CF, Chiang WC, Lin SL, Chen YM, Wu MS.
    Front Immunol; 2021 Jan 23; 12():638309. PubMed ID: 34177889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.